The Company also announced plans to launch a new Investor Relations section on its website https://investor.cloudastructure.com/. This dedicated section will serve as a central resource for ...

NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.

Thumzup Media Corporation, listed on Nasdaq under the symbol TZUP, announced that its Board of Directors has authorized ...

NEW YORK (AP) — The following is a list of initial public offerings planned ... managed by Morgan Stanley BofA. Proposed Nasdaq symbol SFD. Business: Leading US producer of meat products being ...

Beta Bionics (BBNX), a developer of insulin delivery devices, has set terms for an upsized $165M initial public offering.

Tandy Leather Factory, Inc. (the “Company”, Nasdaq: TLF) today announced that it had closed on the sale of its corporate headquarters facilities, including its primary distribution center and flagship ...

"It is a privilege to once again be named to Fortune's list of Most Admired Companies," said Tim Spence, chairman, CEO, and president of Fifth Third. "This recognition highlights how we deliver strong ...

QMSK Technology Co. filed for a 1.5 million-share initial public offering with the Securities and Exchange Commission. The company said Tuesday it expects the IPO to price between $4 and $6 per share.

To receive the Consideration Shares, beneficial shareholders of Foremost as of the Surrender Date whose Foremost Shares are registered in the name of an intermediary (i.e., a bank, trust, company, ...

(Reuters) -Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial public offering in the United States. The South San Francisco, ...

VANCOUVER - Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT), a micro-cap company with a market value of approximately $20 million, announced that it is set to finalize the spin-off of its gold ...

Metsera (MTSR), which is developing ultra-long-acting drugs for the treatment of obesity, has set terms for an upsized $275M initial public offering. In a recent SEC filing, Metsera (MTSR) said it was ...